Biotech - Press Releases

Date	Title	Company
14-Dec-2021	Novavax Files for Emergency Use of COVID-19 Vaccine in the United Arab Emirates	Novavax
14-Dec-2021	Moderna and Australia Announce Collaboration to Bring MRNA Manufacturing to Australia	Moderna
14-Dec-2021	Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccines	Vaccitech plc
14-Dec-2021	Vésale bioscience named most innovative start-up in life sciences in europe at tenth edition of biofit	Andrew Lloyd Associates
14-Dec-2021	Ferrer and cnic unveil results of first real-world study of cnic-polypill showing decreased risk of major adverse cardiovascular events when compared to monocomponents administered separately	Andrew Lloyd Associates
14-Dec-2021	Advent france biotechnology becomes AdBio partners	Andrew Lloyd Associates
14-Dec-2021	HYPNOVR raises €4.5 million to accelerate the roll out of its digital therapy treating pain and anxiety	Andrew Lloyd Associates
13-Dec-2021	Endogena Completes Series A with Total Funding of $29 million to Progress Treatments for Degenerative Diseases of the Eye	Endogena
13-Dec-2021	Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20m to Progress Treatments for Degenerative Diseases of the Eye Holding increased to near-majority in endogenous regenerative medicine pioneer	Rejuveron
10-Dec-2021	ATMPS and Assurea LLC launch strategic collaboration for advanced therapy supply chain	ATMPS Ltd
10-Dec-2021	Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT	Andrew Lloyd Associates
09-Dec-2021	TB Diagnostics company PBD Biotech appoints new CEO	PBD Biotech
09-Dec-2021	OKYO Pharma Limited ("OKYO" or the "Company") to File IND in Q3 2022 for OK-101 to treat Dry Eye Disease ("DED") and to go directly to a Phase 2 Human Clinical Efficacy Trial in DED Patients with a planned start date in Q4 2022 on an accelerated basis	OKYO Pharma Limited
09-Dec-2021	ISA Pharmaceuticals to present key learnings for cancer vaccine development at the ESMO Immuno-Oncology Congress	ISA Pharmaceuticals
09-Dec-2021	Ferrer and CNIC unveil results of first real-world study of CNIC-Polypill showing decreased risk of Major Adverse Cardiovascular Events when compared to monocomponents administered separately	Andrew Lloyd Associates
08-Dec-2021	BioPure receives the keys to its new custom built facility	Watson-Marlow Fluid Technology Group
08-Dec-2021	Creative BioMart Established a Novel Sub-brand Creative BioMart Recombinant Allergen	Creative BioMart
07-Dec-2021	Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference	SMi Group
07-Dec-2021	Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV	Vaccitech plc
07-Dec-2021	Advent France Biotechnology becomes AdBio partners	Andrew Lloyd Associates